EPHA2 and Miyoshi myopathy: However, there are no data connecting progranulin tumorigenic action with non-canonical (ephrinA1-independent) EphA2 activation in MM and therefore no evidence that the progranulin/EphA2 axis might be activated and constitute an oncogenic pathway in MM.